Deoxycholic Acid Triggers NLRP3 Inflammasome Activation and Aggravates DSS-Induced Colitis in Mice
A westernized high-fat diet (HFD) is associated with the development of inflammatory bowel disease (IBD). High-level fecal deoxycholic acid (DCA) caused by HFD contributes to the colonic inflammatory injury of IBD; however, the mechanism concerning the initiation of inflammatory response by DCA rema...
Saved in:
Published in | Frontiers in immunology Vol. 7; p. 536 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
28.11.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A westernized high-fat diet (HFD) is associated with the development of inflammatory bowel disease (IBD). High-level fecal deoxycholic acid (DCA) caused by HFD contributes to the colonic inflammatory injury of IBD; however, the mechanism concerning the initiation of inflammatory response by DCA remains unclear. In this study, we sought to investigate the role and mechanism of DCA in the induction of inflammation
promoting NLRP3 inflammasome activation. Here, we, for the first time, showed that DCA dose-dependently induced NLRP3 inflammasome activation and highly pro-inflammatory cytokine-IL-1β production in macrophages. Mechanistically, DCA-triggered NLRP3 inflammasome activation by promoting cathepsin B release at least partially through sphingosine-1-phosphate receptor 2. Colorectal instillation of DCA significantly increased mature IL-1β level in colonic tissue and exacerbated DSS-induced colitis, while
blockage of NLRP3 inflammasome or macrophage depletion dramatically reduced the mature IL-1β production and ameliorated the aggravated inflammatory injury imposed by DCA. Thus, our findings show that high-level fecal DCA may serve as an endogenous danger signal to activate NLRP3 inflammasome and contribute to HFD-related colonic inflammation. NLRP3 inflammasome may represent a new potential therapeutical target for treatment of IBD. |
---|---|
AbstractList | A westernized high-fat diet (HFD) is associated with the development of inflammatory bowel disease (IBD). High-level fecal deoxycholic acid (DCA) caused by HFD contributes to the colonic inflammatory injury of IBD; however, the mechanism concerning the initiation of inflammatory response by DCA remains unclear. In this study, we sought to investigate the role and mechanism of DCA in the induction of inflammation
via
promoting NLRP3 inflammasome activation. Here, we, for the first time, showed that DCA dose-dependently induced NLRP3 inflammasome activation and highly pro-inflammatory cytokine-IL-1β production in macrophages. Mechanistically, DCA-triggered NLRP3 inflammasome activation by promoting cathepsin B release at least partially through sphingosine-1-phosphate receptor 2. Colorectal instillation of DCA significantly increased mature IL-1β level in colonic tissue and exacerbated DSS-induced colitis, while
in vivo
blockage of NLRP3 inflammasome or macrophage depletion dramatically reduced the mature IL-1β production and ameliorated the aggravated inflammatory injury imposed by DCA. Thus, our findings show that high-level fecal DCA may serve as an endogenous danger signal to activate NLRP3 inflammasome and contribute to HFD-related colonic inflammation. NLRP3 inflammasome may represent a new potential therapeutical target for treatment of IBD. A westernized high-fat diet (HFD) is associated with the development of inflammatory bowel disease (IBD). High-level fecal deoxycholic acid (DCA) caused by HFD contributes to the colonic inflammatory injury of IBD; however, the mechanism concerning the initiation of inflammatory response by DCA remains unclear. In this study, we sought to investigate the role and mechanism of DCA in the induction of inflammation via promoting NLRP3 inflammasome activation. Here, we, for the first time, showed that DCA dose-dependently induced NLRP3 inflammasome activation and highly pro-inflammatory cytokine-IL-1β production in macrophages. Mechanistically, DCA-triggered NLRP3 inflammasome activation by promoting cathepsin B release at least partially through sphingosine-1-phosphate receptor 2. Colorectal instillation of DCA significantly increased mature IL-1β level in colonic tissue and exacerbated DSS-induced colitis, while in vivo blockage of NLRP3 inflammasome or macrophage depletion dramatically reduced the mature IL-1β production and ameliorated the aggravated inflammatory injury imposed by DCA. Thus, our findings show that high-level fecal DCA may serve as an endogenous danger signal to activate NLRP3 inflammasome and contribute to HFD-related colonic inflammation. NLRP3 inflammasome may represent a new potential therapeutical target for treatment of IBD. A westernized high-fat diet (HFD) is associated with the development of inflammatory bowel disease (IBD). High-level fecal deoxycholic acid (DCA) caused by HFD contributes to the colonic inflammatory injury of IBD; however, the mechanism concerning the initiation of inflammatory response by DCA remains unclear. In this study, we sought to investigate the role and mechanism of DCA in the induction of inflammation promoting NLRP3 inflammasome activation. Here, we, for the first time, showed that DCA dose-dependently induced NLRP3 inflammasome activation and highly pro-inflammatory cytokine-IL-1β production in macrophages. Mechanistically, DCA-triggered NLRP3 inflammasome activation by promoting cathepsin B release at least partially through sphingosine-1-phosphate receptor 2. Colorectal instillation of DCA significantly increased mature IL-1β level in colonic tissue and exacerbated DSS-induced colitis, while blockage of NLRP3 inflammasome or macrophage depletion dramatically reduced the mature IL-1β production and ameliorated the aggravated inflammatory injury imposed by DCA. Thus, our findings show that high-level fecal DCA may serve as an endogenous danger signal to activate NLRP3 inflammasome and contribute to HFD-related colonic inflammation. NLRP3 inflammasome may represent a new potential therapeutical target for treatment of IBD. A westernized high-fat diet (HFD) is associated with the development of inflammatory bowel disease (IBD). High level fecal deoxycholic acid (DCA) caused by HFD contributes to the colonic inflammatory injury of IBD, however, the mechanism concerning the initiation of inflammatory response by DCA remains unclear. In this study, we sought to investigate the role and mechanism of DCA in the induction of inflammation via promoting NLRP3 inflammasome activation. Here we for the first time showed that DCA dose-dependently induced NLRP3 inflammasome activation and highly pro-inflammatory cytokine-IL-1β production in macrophages. Mechanistically, DCA triggered NLRP3 inflammasome activation by promoting cathepsin B release at least partially through sphingosine-1-phosphate receptor 2 (S1PR2). Colorectal instillation of DCA significantly increased mature IL-1β level in colonic tissue and exacerbated DSS-induced colitis, while in vivo blockage of NLRP3 inflammasome or macrophage depletion dramatically reduced the mature IL-1β production and ameliorated the aggravated inflammatory injury imposed by DCA. Thus, our findings show that high level fecal DCA may serve as an endogenous danger signal to activate NLRP3 inflammasome and contributes to HFD-related colonic inflammation. NLRP3 inflammasome may represent a new potential therapeutical target for treatment of IBD. |
Author | Gao, Yanhong Zhou, Jiefei Xu, Congfeng Zhao, Shengnan Tian, Chunyan Chen, Yingwei Wu, Jin Gong, Zizhen Cai, Wei |
AuthorAffiliation | 4 State Key Laboratory of Proteomics, National Center for Proteomics Science, Beijing Institute of Radiation Medicine , Beijing , China 7 Shanghai Institute of Immunology, Institutes of Medical Sciences, Shanghai Jiaotong University School of Medicine , Shanghai , China 3 Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition , Shanghai , China 2 Shanghai Institute for Pediatric Research, Shanghai Jiaotong University School of Medicine , Shanghai , China 5 National Engineering Research Center for Protein Drugs , Beijing , China 1 Department of Pediatric Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine , Shanghai , China 6 Department of Geriatrics, Xinhua Hospital, Shanghai Jiaotong University School of Medicine , Shanghai , China |
AuthorAffiliation_xml | – name: 4 State Key Laboratory of Proteomics, National Center for Proteomics Science, Beijing Institute of Radiation Medicine , Beijing , China – name: 6 Department of Geriatrics, Xinhua Hospital, Shanghai Jiaotong University School of Medicine , Shanghai , China – name: 3 Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition , Shanghai , China – name: 1 Department of Pediatric Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine , Shanghai , China – name: 2 Shanghai Institute for Pediatric Research, Shanghai Jiaotong University School of Medicine , Shanghai , China – name: 5 National Engineering Research Center for Protein Drugs , Beijing , China – name: 7 Shanghai Institute of Immunology, Institutes of Medical Sciences, Shanghai Jiaotong University School of Medicine , Shanghai , China |
Author_xml | – sequence: 1 givenname: Shengnan surname: Zhao fullname: Zhao, Shengnan organization: Department of Pediatric Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Shanghai Institute for Pediatric Research, Shanghai Jiaotong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Shanghai, China – sequence: 2 givenname: Zizhen surname: Gong fullname: Gong, Zizhen organization: Department of Pediatric Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Shanghai Institute for Pediatric Research, Shanghai Jiaotong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Shanghai, China – sequence: 3 givenname: Jiefei surname: Zhou fullname: Zhou, Jiefei organization: Department of Pediatric Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Shanghai Institute for Pediatric Research, Shanghai Jiaotong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Shanghai, China – sequence: 4 givenname: Chunyan surname: Tian fullname: Tian, Chunyan organization: State Key Laboratory of Proteomics, National Center for Proteomics Science, Beijing Institute of Radiation Medicine, Beijing, China; National Engineering Research Center for Protein Drugs, Beijing, China – sequence: 5 givenname: Yanhong surname: Gao fullname: Gao, Yanhong organization: Department of Geriatrics, Xinhua Hospital, Shanghai Jiaotong University School of Medicine , Shanghai , China – sequence: 6 givenname: Congfeng surname: Xu fullname: Xu, Congfeng organization: Shanghai Institute of Immunology, Institutes of Medical Sciences, Shanghai Jiaotong University School of Medicine , Shanghai , China – sequence: 7 givenname: Yingwei surname: Chen fullname: Chen, Yingwei organization: Shanghai Institute for Pediatric Research, Shanghai Jiaotong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Shanghai, China – sequence: 8 givenname: Wei surname: Cai fullname: Cai, Wei organization: Department of Pediatric Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Shanghai Institute for Pediatric Research, Shanghai Jiaotong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Shanghai, China – sequence: 9 givenname: Jin surname: Wu fullname: Wu, Jin organization: Department of Pediatric Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China; Shanghai Institute for Pediatric Research, Shanghai Jiaotong University School of Medicine, Shanghai, China; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Shanghai, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27965665$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkc1P3DAQxa0KVD7KvafKx16y9Udsx5dKq6WlK20BFXq2HGcSjBKb2gkq_32zuxSBL_aM3_zmSe8EHYQYAKGPlCw4r_SX1g_DtGCEygUhgst36JhKWRacsfLg1fsIneV8T-ZTas65eI-OmNJSSCmOUX0O8e-Tu4u9d3jpfINvk-86SBlfbn5dc7wObW-HweY4wCwY_aMdfQzYhgYvuy7ZuYaMz29uinVoJgcNXs2w0WfsA_7pHXxAh63tM5w936fo9_dvt6sfxebqYr1abgonRDkW0BKltSbcVVVZSlkRDUxY0dCG1QqgFnWlGGlF01on6pLRShFWcaGJJFZLforWe24T7b15SH6w6clE682uEVNnbBq968EAIZyo1rXK2lLQsq6hqpVkgurZjNuyvu5ZD1M9QOMgjMn2b6Bvf4K_M118NIKy2fsW8PkZkOKfCfJoBp8d9L0NEKdsaCWYVIoJNkvJXupSzDlB-7KGErNN2uySNtukzS7peeTTa3svA_9z5f8Aj4OmRw |
CitedBy_id | crossref_primary_10_1038_mi_2017_19 crossref_primary_10_1002_jcp_30024 crossref_primary_10_1093_toxsci_kfz099 crossref_primary_10_3389_fphys_2020_00564 crossref_primary_10_1155_2018_2481418 crossref_primary_10_1124_pharmrev_120_000171 crossref_primary_10_3390_ijms23116292 crossref_primary_10_1016_j_plipres_2022_101210 crossref_primary_10_3390_cells11152337 crossref_primary_10_1016_j_tem_2018_08_002 crossref_primary_10_1111_imm_13056 crossref_primary_10_3390_cimb45070351 crossref_primary_10_3389_fphar_2023_1178596 crossref_primary_10_1093_ibd_izaa342 crossref_primary_10_1016_j_lfs_2021_120152 crossref_primary_10_3389_fphar_2024_1361643 crossref_primary_10_3390_cancers13164054 crossref_primary_10_3389_fmed_2022_814839 crossref_primary_10_1152_ajpgi_00002_2022 crossref_primary_10_1016_j_autrev_2018_01_020 crossref_primary_10_3390_molecules26061725 crossref_primary_10_1155_2019_8495913 crossref_primary_10_1111_jgh_15509 crossref_primary_10_1093_ecco_jcc_jjab003 crossref_primary_10_3390_nu13113839 crossref_primary_10_1186_s40104_023_00830_7 crossref_primary_10_1016_j_phrs_2021_105694 crossref_primary_10_31146_1682_8658_ecg_215_7_25_33 crossref_primary_10_1016_j_phrs_2023_106983 crossref_primary_10_1186_s40168_023_01546_6 crossref_primary_10_1128_mSystems_00116_21 crossref_primary_10_1016_j_yexcr_2023_113781 crossref_primary_10_1016_j_bbrc_2020_01_159 crossref_primary_10_1080_19490976_2022_2107387 crossref_primary_10_1016_j_it_2021_07_005 crossref_primary_10_1042_BSR20200689 crossref_primary_10_1136_gutjnl_2018_316670 crossref_primary_10_1007_s11726_023_1364_6 crossref_primary_10_1016_j_cmet_2024_06_008 crossref_primary_10_1186_s12917_021_02755_7 crossref_primary_10_3389_fimmu_2019_01706 crossref_primary_10_1016_j_bcp_2018_07_027 crossref_primary_10_1080_19490976_2018_1526580 crossref_primary_10_3389_fimmu_2022_1021924 crossref_primary_10_1038_s41598_020_64054_9 crossref_primary_10_3389_fimmu_2020_604989 crossref_primary_10_1016_j_isci_2024_109118 crossref_primary_10_3389_fimmu_2023_1285357 crossref_primary_10_3390_cells10102618 crossref_primary_10_3389_fmed_2022_1009324 crossref_primary_10_3389_fphar_2022_677738 crossref_primary_10_1093_toxsci_kfab027 crossref_primary_10_1016_j_cytogfr_2021_03_003 crossref_primary_10_1152_physrev_00054_2017 crossref_primary_10_1080_19490976_2020_1819155 crossref_primary_10_1016_j_biopha_2024_116679 crossref_primary_10_1096_fj_202201728R crossref_primary_10_1093_nutrit_nuac039 crossref_primary_10_1186_s13578_023_01109_0 crossref_primary_10_1016_j_molimm_2018_09_004 crossref_primary_10_3390_ijms21134733 crossref_primary_10_21508_1027_4065_2024_69_1_58_65 crossref_primary_10_1016_j_chembiol_2024_04_006 crossref_primary_10_1111_imm_12930 crossref_primary_10_1016_j_phrs_2020_105412 crossref_primary_10_1016_j_apsb_2021_12_011 |
Cites_doi | 10.1016/j.cell.2010.01.022 10.3791/4105 10.1053/j.gastro.2011.10.001 10.1136/gut.2009.197822 10.1124/jpet.103.057059 10.1128/MCB.26.3.735-742.2006 10.1091/mbc.E03-12-0894 10.1038/nri3452 10.1111/j.1365-2249.2004.02599.x 10.1038/nrgastro.2013.151 10.1093/carcin/bgl139 10.1038/nature04516 10.1016/j.immuni.2013.05.016 10.1186/1476-511X-10-204 10.1084/jem.20111453 10.1136/gut.31.6.686 10.1111/apt.12500 10.1073/pnas.231473998 10.1053/j.gastro.2008.08.051 10.1161/ATVBAHA.110.213496 10.1038/ajg.2011.44 10.1016/j.cell.2010.01.040 10.1038/ni.1631 10.1038/nature08938 10.1371/journal.pone.0156303 10.1136/gut.42.2.214 10.3748/wjg.v18.i9.923 10.1038/nm.3265 10.1152/ajpgi.00043.2007 10.3389/fphys.2014.00352 10.1038/mi.2014.1 10.1074/jbc.M114.579961 10.1007/s10620-007-9802-8 10.1038/ng.285 10.1016/j.cell.2014.02.008 10.1038/ni.1703 10.1152/ajpgi.00267.2012 10.1007/s10620-014-3190-7 10.1038/ni.1831 10.1158/0008-5472.CAN-13-2329 10.1016/j.cell.2007.12.040 10.1084/jem.20030680 10.1016/j.cellsig.2006.06.007 10.1016/j.steroids.2014.04.016 10.1159/000177961 10.1016/j.immuni.2016.09.008 10.1097/01.MIB.0000209789.14114.63 10.3945/jn.113.180810 10.1126/science.1184003 |
ContentType | Journal Article |
Copyright | Copyright © 2016 Zhao, Gong, Zhou, Tian, Gao, Xu, Chen, Cai and Wu. 2016 Zhao, Gong, Zhou, Tian, Gao, Xu, Chen, Cai and Wu |
Copyright_xml | – notice: Copyright © 2016 Zhao, Gong, Zhou, Tian, Gao, Xu, Chen, Cai and Wu. 2016 Zhao, Gong, Zhou, Tian, Gao, Xu, Chen, Cai and Wu |
DBID | NPM AAYXX CITATION 7X8 5PM DOA |
DOI | 10.3389/fimmu.2016.00536 |
DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1664-3224 |
EndPage | 536 |
ExternalDocumentID | oai_doaj_org_article_e00307fcf7aa4514bbe8b762519c55c6 10_3389_fimmu_2016_00536 27965665 |
Genre | Journal Article |
GrantInformation_xml | – fundername: Natural Science Foundation of Shanghai grantid: 16ZR1428500 – fundername: National Natural Science Foundation of China grantid: 81201602 |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV DIK EBS EMOBN GROUPED_DOAJ GX1 HYE IAO IEA IHR IHW IPNFZ KQ8 M48 M~E NPM OK1 PGMZT RIG RNS RPM AAYXX CITATION 7X8 ITC 5PM |
ID | FETCH-LOGICAL-c554t-ef0799903c884466809e25a5d1d2b7eeb5b8720f5dfac5b42187028359060a963 |
IEDL.DBID | RPM |
ISSN | 1664-3224 |
IngestDate | Fri Oct 04 13:14:28 EDT 2024 Tue Sep 17 21:26:25 EDT 2024 Fri Aug 16 08:07:55 EDT 2024 Thu Sep 26 16:09:46 EDT 2024 Sat Sep 28 07:58:41 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | IL-1β bile acid inflammation inflammasome inflammatory bowel disease high-fat diet |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c554t-ef0799903c884466809e25a5d1d2b7eeb5b8720f5dfac5b42187028359060a963 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Reviewed by: Nobuhiko Kamada, University of Michigan Health System, USA; Alberto Finamore, Consiglio per la ricerca in agricoltura e l’analisi dell’economia agraria (CREA), Italy Edited by: Lorraine M. Sordillo, Michigan State University, USA Specialty section: This article was submitted to Nutritional Immunology, a section of the journal Frontiers in Immunology |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124666/ |
PMID | 27965665 |
PQID | 1852677252 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_e00307fcf7aa4514bbe8b762519c55c6 pubmedcentral_primary_oai_pubmedcentral_nih_gov_5124666 proquest_miscellaneous_1852677252 crossref_primary_10_3389_fimmu_2016_00536 pubmed_primary_27965665 |
PublicationCentury | 2000 |
PublicationDate | 2016-11-28 |
PublicationDateYYYYMMDD | 2016-11-28 |
PublicationDate_xml | – month: 11 year: 2016 text: 2016-11-28 day: 28 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in immunology |
PublicationTitleAlternate | Front Immunol |
PublicationYear | 2016 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | 20303873 - Cell. 2010 Mar 19;140(6):821-32 25288801 - J Biol Chem. 2014 Nov 21;289(47):32926-36 16996249 - Cell Signal. 2007 Feb;19(2):251-60 23702978 - Nat Rev Immunol. 2013 Jun;13(6):397-411 11606779 - Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13249-54 22408351 - World J Gastroenterol. 2012 Mar 7;18(9):923-9 16633050 - Inflamm Bowel Dis. 2006 Apr;12(4):278-93 15067032 - J Exp Med. 2004 Apr 5;199(7):959-70 24102340 - Aliment Pharmacol Ther. 2013 Nov;38(10):1156-71 2379873 - Gut. 1990 Jun;31(6):686-9 27224249 - PLoS One. 2016 May 25;11(5):e0156303 17393315 - Dig Dis Sci. 2007 Jul;52(7):1642-52 18604214 - Nat Immunol. 2008 Aug;9(8):847-56 20442201 - Gut. 2010 Sep;59(9):1192-9 24472848 - Mucosal Immunol. 2014 Sep;7(5):1139-50 24819989 - Steroids. 2014 Aug;86:62-8 12646507 - Cancer Epidemiol Biomarkers Prev. 2003 Mar;12(3):197-200 19221555 - Nat Immunol. 2009 Mar;10 (3):241-7 20947824 - Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):81-5 9536946 - Gut. 1998 Feb;42(2):214-9 24520077 - Cancer Res. 2014 Apr 1;74(7):2062-72 20303872 - Cell. 2010 Mar 19;140(6):805-20 18329368 - Cell. 2008 Mar 7;132(5):818-31 9429694 - Ann Nutr Metab. 1997;41(5):315-23 27692610 - Immunity. 2016 Oct 18;45(4):802-816 22871793 - J Vis Exp. 2012 Aug 01;(66):4105 20428172 - Nature. 2010 Apr 29;464(7293):1357-61 16407889 - Nature. 2006 Mar 9;440(7081):237-41 16887864 - Carcinogenesis. 2007 Jan;28(1):215-22 21468064 - Am J Gastroenterol. 2011 Apr;106(4):563-73 23982684 - Nat Rev Gastroenterol Hepatol. 2014 Jan;11(1):55-67 22073943 - Lipids Health Dis. 2011 Nov 10;10:204 25324778 - Front Physiol. 2014 Sep 29;5:352 22891275 - J Exp Med. 2012 Aug 27;209(9):1595-609 18239063 - Am J Physiol Gastrointest Liver Physiol. 2008 Apr;294(4):G906-13 23203158 - Am J Physiol Gastrointest Liver Physiol. 2013 Feb 1;304(3):G227-34 15498044 - Clin Exp Immunol. 2004 Nov;138(2):323-9 20075245 - Science. 2010 Jan 15;327(5963):296-300 19098911 - Nat Genet. 2009 Jan;41(1):71-6 23809161 - Immunity. 2013 Jun 27;38(6):1142-53 24630722 - Cell. 2014 Mar 13;156(6):1193-206 24047703 - J Nutr. 2013 Nov;143(11):1691-7 23955712 - Nat Med. 2013 Sep;19(9):1132-40 19000677 - Gastroenterology. 2008 Dec;135(6):2075-83 22001864 - Gastroenterology. 2012 Jan;142(1):46-54.e42; quiz e30 16428431 - Mol Cell Biol. 2006 Feb;26(3):735-42 20023662 - Nat Immunol. 2010 Feb;11(2):136-40 14610233 - J Pharmacol Exp Ther. 2004 Feb;308(2):583-90 25027205 - Dig Dis Sci. 2014 Oct;59(10):2367-80 15004225 - Mol Biol Cell. 2004 May;15(5):2156-63 Traub (B10) 2008; 135 Weisser (B30) 2012; 66 Ligumsky (B25) 1990; 31 Stenman (B3) 2013; 143 Hornung (B40) 2008; 9 Stenman (B7) 2012; 18 Centuori (B50) 2014; 59 Teixeira (B46) 2011; 10 Franchi (B13) 2009; 10 McAlindon (B23) 1998; 42 Nagathihalli (B5) 2014; 74 Loher (B27) 2004; 308 Guo (B44) 2016; 45 Hou (B1) 2011; 106 Ludwiczek (B24) 2004; 138 Schroder (B16) 2010; 327 Zhang (B19) 2014; 7 Schaap (B37) 2014; 11 Skoura (B43) 2011; 31 Stenman (B9) 2013; 304 Didierlaurent (B29) 2006; 26 Bartram (B49) 1997; 41 Villani (B20) 2009; 41 Martinon (B41) 2006; 440 Okada (B36) 2014; 289 Latz (B18) 2013; 13 Coccia (B26) 2012; 209 Lu (B15) 2014; 156 Zhou (B34) 2010; 11 Munoz-Planillo (B33) 2013; 38 Jolly (B39) 2004; 199 Jourdan (B32) 2013; 19 Pai (B48) 2004; 15 Tan (B45) 2007; 19 Molodecky (B2) 2012; 142 Richman (B47) 2013; 38 Schroder (B17) 2010; 140 Payne (B4) 2007; 28 Harijith (B35) 2014; 5 Alberts (B6) 2003; 12 Duewell (B31) 2010; 464 Yu (B42) 2016; 11 Zhou (B38) 2014; 86 Siegmund (B21) 2001; 98 Raimondi (B8) 2008; 294 Bauer (B22) 2010; 59 Takeuchi (B12) 2010; 140 Keller (B14) 2008; 132 Bernstein (B11) 2006; 12 Bauer (B28) 2007; 52 |
References_xml | – volume: 140 start-page: 805 year: 2010 ident: B12 article-title: Pattern recognition receptors and inflammation publication-title: Cell doi: 10.1016/j.cell.2010.01.022 contributor: fullname: Takeuchi – volume: 66 start-page: 4105 year: 2012 ident: B30 article-title: Depletion and reconstitution of macrophages in mice publication-title: J Vis Exp doi: 10.3791/4105 contributor: fullname: Weisser – volume: 142 start-page: 46 year: 2012 ident: B2 article-title: Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review publication-title: Gastroenterology doi: 10.1053/j.gastro.2011.10.001 contributor: fullname: Molodecky – volume: 59 start-page: 1192 year: 2010 ident: B22 article-title: Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome publication-title: Gut doi: 10.1136/gut.2009.197822 contributor: fullname: Bauer – volume: 308 start-page: 583 year: 2004 ident: B27 article-title: The interleukin-1 beta-converting enzyme inhibitor pralnacasan reduces dextran sulfate sodium-induced murine colitis and T helper 1 T-cell activation publication-title: J Pharmacol Exp Ther doi: 10.1124/jpet.103.057059 contributor: fullname: Loher – volume: 26 start-page: 735 year: 2006 ident: B29 article-title: Tollip regulates proinflammatory responses to interleukin-1 and lipopolysaccharide publication-title: Mol Cell Biol doi: 10.1128/MCB.26.3.735-742.2006 contributor: fullname: Didierlaurent – volume: 15 start-page: 2156 year: 2004 ident: B48 article-title: Deoxycholic acid activates beta-catenin signaling pathway and increases colon cell cancer growth and invasiveness publication-title: Mol Biol Cell doi: 10.1091/mbc.E03-12-0894 contributor: fullname: Pai – volume: 13 start-page: 397 year: 2013 ident: B18 article-title: Activation and regulation of the inflammasomes publication-title: Nat Rev Immunol doi: 10.1038/nri3452 contributor: fullname: Latz – volume: 138 start-page: 323 year: 2004 ident: B24 article-title: Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease publication-title: Clin Exp Immunol doi: 10.1111/j.1365-2249.2004.02599.x contributor: fullname: Ludwiczek – volume: 11 start-page: 55 year: 2014 ident: B37 article-title: Bile acid receptors as targets for drug development publication-title: Nat Rev Gastroenterol Hepatol doi: 10.1038/nrgastro.2013.151 contributor: fullname: Schaap – volume: 28 start-page: 215 year: 2007 ident: B4 article-title: Deoxycholate induces mitochondrial oxidative stress and activates NF-kappaB through multiple mechanisms in HCT-116 colon epithelial cells publication-title: Carcinogenesis doi: 10.1093/carcin/bgl139 contributor: fullname: Payne – volume: 440 start-page: 237 year: 2006 ident: B41 article-title: Gout-associated uric acid crystals activate the NALP3 inflammasome publication-title: Nature doi: 10.1038/nature04516 contributor: fullname: Martinon – volume: 38 start-page: 1142 year: 2013 ident: B33 article-title: K(+) efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter publication-title: Immunity doi: 10.1016/j.immuni.2013.05.016 contributor: fullname: Munoz-Planillo – volume: 10 start-page: 204 year: 2011 ident: B46 article-title: The combination of high-fat diet-induced obesity and chronic ulcerative colitis reciprocally exacerbates adipose tissue and colon inflammation publication-title: Lipids Health Dis doi: 10.1186/1476-511X-10-204 contributor: fullname: Teixeira – volume: 209 start-page: 1595 year: 2012 ident: B26 article-title: IL-1beta mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells publication-title: J Exp Med doi: 10.1084/jem.20111453 contributor: fullname: Coccia – volume: 31 start-page: 686 year: 1990 ident: B25 article-title: Role of interleukin 1 in inflammatory bowel disease – enhanced production during active disease publication-title: Gut doi: 10.1136/gut.31.6.686 contributor: fullname: Ligumsky – volume: 38 start-page: 1156 year: 2013 ident: B47 article-title: Review article: evidence-based dietary advice for patients with inflammatory bowel disease publication-title: Aliment Pharmacol Ther doi: 10.1111/apt.12500 contributor: fullname: Richman – volume: 98 start-page: 13249 year: 2001 ident: B21 article-title: IL-1 beta-converting enzyme (caspase-1) in intestinal inflammation publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.231473998 contributor: fullname: Siegmund – volume: 135 start-page: 2075 year: 2008 ident: B10 article-title: A rat model of chronic postinflammatory visceral pain induced by deoxycholic acid publication-title: Gastroenterology doi: 10.1053/j.gastro.2008.08.051 contributor: fullname: Traub – volume: 31 start-page: 81 year: 2011 ident: B43 article-title: Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.110.213496 contributor: fullname: Skoura – volume: 106 start-page: 563 year: 2011 ident: B1 article-title: Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature publication-title: Am J Gastroenterol doi: 10.1038/ajg.2011.44 contributor: fullname: Hou – volume: 140 start-page: 821 year: 2010 ident: B17 article-title: The inflammasomes publication-title: Cell doi: 10.1016/j.cell.2010.01.040 contributor: fullname: Schroder – volume: 9 start-page: 847 year: 2008 ident: B40 article-title: Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization publication-title: Nat Immunol doi: 10.1038/ni.1631 contributor: fullname: Hornung – volume: 464 start-page: 1357 year: 2010 ident: B31 article-title: NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals publication-title: Nature doi: 10.1038/nature08938 contributor: fullname: Duewell – volume: 11 start-page: e0156303 year: 2016 ident: B42 article-title: Sphingosine-1-phosphate receptor 2 regulates proinflammatory cytokine production and osteoclastogenesis publication-title: PLoS One doi: 10.1371/journal.pone.0156303 contributor: fullname: Yu – volume: 42 start-page: 214 year: 1998 ident: B23 article-title: Expression of interleukin 1 beta and interleukin 1 beta converting enzyme by intestinal macrophages in health and inflammatory bowel disease publication-title: Gut doi: 10.1136/gut.42.2.214 contributor: fullname: McAlindon – volume: 18 start-page: 923 year: 2012 ident: B7 article-title: High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids publication-title: World J Gastroenterol doi: 10.3748/wjg.v18.i9.923 contributor: fullname: Stenman – volume: 19 start-page: 1132 year: 2013 ident: B32 article-title: Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes publication-title: Nat Med doi: 10.1038/nm.3265 contributor: fullname: Jourdan – volume: 294 start-page: G906 year: 2008 ident: B8 article-title: Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.00043.2007 contributor: fullname: Raimondi – volume: 5 start-page: 352 year: 2014 ident: B35 article-title: Reactive oxygen species at the crossroads of inflammasome and inflammation publication-title: Front Physiol doi: 10.3389/fphys.2014.00352 contributor: fullname: Harijith – volume: 7 start-page: 1139 year: 2014 ident: B19 article-title: Inflammasome activation has an important role in the development of spontaneous colitis publication-title: Mucosal Immunol doi: 10.1038/mi.2014.1 contributor: fullname: Zhang – volume: 289 start-page: 32926 year: 2014 ident: B36 article-title: The lysosome rupture-activated TAK1-JNK pathway regulates NLRP3 inflammasome activation publication-title: J Biol Chem doi: 10.1074/jbc.M114.579961 contributor: fullname: Okada – volume: 52 start-page: 1642 year: 2007 ident: B28 article-title: The ICE inhibitor pralnacasan prevents DSS-induced colitis in C57BL/6 mice and suppresses IP-10 mRNA but not TNF-alpha mRNA expression publication-title: Dig Dis Sci doi: 10.1007/s10620-007-9802-8 contributor: fullname: Bauer – volume: 41 start-page: 71 year: 2009 ident: B20 article-title: Common variants in the NLRP3 region contribute to Crohn’s disease susceptibility publication-title: Nat Genet doi: 10.1038/ng.285 contributor: fullname: Villani – volume: 156 start-page: 1193 year: 2014 ident: B15 article-title: Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes publication-title: Cell doi: 10.1016/j.cell.2014.02.008 contributor: fullname: Lu – volume: 12 start-page: 197 year: 2003 ident: B6 article-title: Fecal bile acid concentrations in a subpopulation of the wheat bran fiber colon polyp trial publication-title: Cancer Epidemiol Biomarkers Prev contributor: fullname: Alberts – volume: 10 start-page: 241 year: 2009 ident: B13 article-title: The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis publication-title: Nat Immunol doi: 10.1038/ni.1703 contributor: fullname: Franchi – volume: 304 start-page: G227 year: 2013 ident: B9 article-title: A novel mechanism for gut barrier dysfunction by dietary fat: epithelial disruption by hydrophobic bile acids publication-title: Am J Physiol Gastrointest Liver Physiol doi: 10.1152/ajpgi.00267.2012 contributor: fullname: Stenman – volume: 59 start-page: 2367 year: 2014 ident: B50 article-title: Differential regulation of EGFR-MAPK signaling by deoxycholic acid (DCA) and ursodeoxycholic acid (UDCA) in colon cancer publication-title: Dig Dis Sci doi: 10.1007/s10620-014-3190-7 contributor: fullname: Centuori – volume: 11 start-page: 136 year: 2010 ident: B34 article-title: Thioredoxin-interacting protein links oxidative stress to inflammasome activation publication-title: Nat Immunol doi: 10.1038/ni.1831 contributor: fullname: Zhou – volume: 74 start-page: 2062 year: 2014 ident: B5 article-title: Novel mechanistic insights into ectodomain shedding of EGFR ligands amphiregulin and TGF-alpha: impact on gastrointestinal cancers driven by secondary bile acids publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-13-2329 contributor: fullname: Nagathihalli – volume: 132 start-page: 818 year: 2008 ident: B14 article-title: Active caspase-1 is a regulator of unconventional protein secretion publication-title: Cell doi: 10.1016/j.cell.2007.12.040 contributor: fullname: Keller – volume: 199 start-page: 959 year: 2004 ident: B39 article-title: Transactivation of sphingosine-1-phosphate receptors by FcepsilonRI triggering is required for normal mast cell degranulation and chemotaxis publication-title: J Exp Med doi: 10.1084/jem.20030680 contributor: fullname: Jolly – volume: 19 start-page: 251 year: 2007 ident: B45 article-title: Beta2 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-kappaB-independent mechanisms publication-title: Cell Signal doi: 10.1016/j.cellsig.2006.06.007 contributor: fullname: Tan – volume: 86 start-page: 62 year: 2014 ident: B38 article-title: Bile acids are nutrient signaling hormones publication-title: Steroids doi: 10.1016/j.steroids.2014.04.016 contributor: fullname: Zhou – volume: 41 start-page: 315 year: 1997 ident: B49 article-title: Effects of calcium and deoxycholic acid on human colonic cell proliferation in vitro publication-title: Ann Nutr Metab doi: 10.1159/000177961 contributor: fullname: Bartram – volume: 45 start-page: 802 issue: 4 year: 2016 ident: B44 article-title: Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome publication-title: Immunity doi: 10.1016/j.immuni.2016.09.008 contributor: fullname: Guo – volume: 12 start-page: 278 year: 2006 ident: B11 article-title: Unique dietary-related mouse model of colitis publication-title: Inflamm Bowel Dis doi: 10.1097/01.MIB.0000209789.14114.63 contributor: fullname: Bernstein – volume: 143 start-page: 1691 year: 2013 ident: B3 article-title: Higher fecal bile acid hydrophobicity is associated with exacerbation of dextran sodium sulfate colitis in mice publication-title: J Nutr doi: 10.3945/jn.113.180810 contributor: fullname: Stenman – volume: 327 start-page: 296 year: 2010 ident: B16 article-title: The NLRP3 inflammasome: a sensor for metabolic danger? publication-title: Science doi: 10.1126/science.1184003 contributor: fullname: Schroder |
SSID | ssj0000493335 |
Score | 2.4538355 |
Snippet | A westernized high-fat diet (HFD) is associated with the development of inflammatory bowel disease (IBD). High-level fecal deoxycholic acid (DCA) caused by HFD... A westernized high-fat diet (HFD) is associated with the development of inflammatory bowel disease (IBD). High level fecal deoxycholic acid (DCA) caused by HFD... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 536 |
SubjectTerms | Bile acid high fat diet IL-1beta Immunology Inflammasome Inflammation Inflammatory Bowel Diseases |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1JS8QwFA4iCF7E3boRwYuHYqdp2vToiogO4ih4Cy9pqiNMR5wZ0H_ve8moMyJ48dqFhu_L8r2-jbF9AOOcARmLUuRx5ioXGwG4GZaZRXlglEkoOfm6nV_cZ5cP8mGi1RfFhIXywAG4Q-enYW3rAiDD090YpwyuYFQeVkobim235IQx9Rx0rxBCBr8kWmHlYd3t9UYUykXOB-krMn-fQ75c_28a82eo5MTZc77IFsaikR-FwS6xGdcss7nQRvJ9hZlT13_z-1jXcrDdig_R5n5EYcfbV7c3guMsQuJ7MOj3HKdMhvAflkNTcXikDkSkOPlppxOjiY5kV9z6uLgBvsqpYf0quz8_uzu5iMe9E2JEJRvGrk4K1H6JsEqRy1YlpUslyKpVpaZAeqRRRZrUsqrBSpPhSV-Q1JBlkieAq3KNzTb9xm0wDmnuatsqgRIWIJXKkmpRVFk-ya1QETv4RFK_hBIZGk0LQl171DWhrj3qETsmqL-eo-LW_gJSrseU678oj9jeJ1EaFwN5OKBx_dFAUyZ4jvaCTCO2Hoj7-lRalKRdZcSKKUqnxjJ9p-k--YLbKIoQwnzzPwa_xeYJDkpnTNU2mx2-jtwO6pqh2fVT-APCRPbS priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjZ1Lb9QwEICt0gqJC6Ll0YUWGYkLh0DWrzgHVG1bqoLYCtGu1JtlO842FZvAPqT233fGyRYW7aHXxLKT8Xj8jeyZIeS9tS4EZ2XCc64SEYqQOG7BGObCAx447VIMTh6eqdOR-HYpL_-GR3cCnK117bCe1Gj66-PNn9sDWPCf0eOE_fZTWU0mC7ylhecKkqtHZIsJLlDfhx3sX7cszHmsuNlXSiSgyaI9t1zbyco-FdP5r2PQ_69S_rM3nTwjTzuopINWC7bJRqh3yOO2zOTtc-KOQ3MT7Vzl6cBXBb0An3wM4EfPvv_8wenXugTFmNhZMwnQYFnxjNq6oIMxVihCIqXH5-cJlvrwoaBH8d7cjFY1HYKteUFGJ18ujk6TrrZC4gEg5kko0wzYMOVeazzS1WkemLSy6BfMZTB90umMpaUsSuulE0ACGaKIzFOVWli1L8lm3dRhl1DLVCh9P7cY0GCZ1B6pRmPm-VR5rnvkw1KS5nebQsOA64FSN1HqBqVuotR75BBFfd8Ok1_HB810bLq1ZEK0TKUvM2sFAJ9zQTsw6gCj8HMeOnm3nCgDiwVPQGwdmsXMYKS4An9Csh551U7c_VAsy5FtZY9kK1O68i2rb-rqKibkBmgCEarXDxj3DXmCf4vRjEzvkc35dBH2AWvm7m3U1jtiGPTc priority: 102 providerName: Scholars Portal |
Title | Deoxycholic Acid Triggers NLRP3 Inflammasome Activation and Aggravates DSS-Induced Colitis in Mice |
URI | https://www.ncbi.nlm.nih.gov/pubmed/27965665 https://search.proquest.com/docview/1852677252 https://pubmed.ncbi.nlm.nih.gov/PMC5124666 https://doaj.org/article/e00307fcf7aa4514bbe8b762519c55c6 |
Volume | 7 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NT9swFH8CpEm7TPte2UCetMsOoWkcJ86xFBhDFKEBUm-W7ThdJuIg2krbf897ToPotNMuOSRO4vhnP_9e3hfAF62Nc0aLiBc8i1JXushwjcKwSC3SAyNNTMHJ04vs9CY9m4nZFog-FiY47VtTH_jb5sDXP4Nv5V1jh72f2PByOsFNKkXaPdyG7ZzzJyr6r47ycs5FZ5JEBawYVnXTrMiLi-wOglPVoiQviMiIjd0oJO3_F9P822HyyQ508hJerKkjG3ddfAVbzr-GZ10xyT9vwBy59neQZrVlY1uX7Bo17znSO3Zx_uOSs---QvgbvWgbhw36umZM-5KN51SHiHgnO7q6iqigh3UlmwTvuAWrPZuiRHkLNyfH15PTaF1BIbJIE5aRq-IcGWDMrZRkuJVx4RKhRTkqE5MjSMLIPIkrUVbaCpPifp8T4RBFnMUa1-Y72PGtdx-A6SRzlR0VmsIWdCKkJe4iKb98nFkuB_C1H0l11yXKUKhgEAAqAKAIABUAGMAhDfVjO0pxHU6093O1Blq5IH8qW-Vap0jrjHHSoOhGyokfZ_Ehn3ugFC4JsnNo79rVQlE8eIZag0gG8L4D7vFVPfADyDcg3ejL5hWchSHt9nrW7f73nR_hOY0BRTIm8hPsLO9Xbg8pzdLsh18BePw2G-Fxmsr9MKkfAL3T-Qc |
link.rule.ids | 230,315,733,786,790,870,891,2115,24346,27955,27956,53825,53827 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEB6VIkQvvCnhuUhcODhxvV57fQwpVQpJVNEU9bbaXa-DW-xUTXJofz0z67hqKi5w9drexzz2G80L4JPWxjmjRcAzngSxy11guEZlmMUW4YGRJqTk5PEkGZ7E307F6RaINhfGB-1bU3br31W3Ln_52MqLyvbaOLHe0XiAl1SMsLt3D-6jvEbilpF-1oBezrlonJJogmW9oqyqFcVxkedBcOpbFKUZQRmxcR_5sv1_w5p3QyZv3UEHj-Fnu_om9OS8u1qarr2-U9jxn7f3BB6tUSnrN8NPYcvVz-BB06fy6jmYfYczkqIsLevbMmdTNOpniBzZZPTjiLPDukDOqvRiXjl8oW2ZxnSds_6MWhwRpGX7x8cB9QqxLmcDH3i3YGXNxqisXsDJwdfpYBismzMEFhHIMnBFmCK4DLmVknzCMsxcJLTI9_LIpEh_YWQahYXIC22FiRFKpIRlRBYmoUaxfwnb9bx2r4DpKHGF3cs0ZUToSEhLsEhS6fowsVx24HNLInXR1OBQaLsQZZWnrCLKKk_ZDnwhGt68R9Wz_YP55UytD1k5r9oKW6Rax4gYjXHS4K2AaBY3Z_EnH1sOUCht5ELRtZuvFopSzRM0SETUgd2GI26majmqA-kGr2ysZXMEOcBX9F5T_PV_f_kBHg6n45EaHU6-v4EdOg9KmIzkW9heXq7cO0ROS_Pey8kfN4MYSg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Lb9MwGLdgCMRl4zVWxsNIXDikyeI4cY6lpdpgrSq2SRMXy3acEra41doe4K_n-5xmaidOuybOw_5ev0_fi5BPSmlrteIBy1kaJLawgWYKlGGeGIAHWugIi5NH4_T4Ivl2yS83Rn35pH2jq667rruu-uVzK-e1Cds8sXAy6oORSgB2h_OiDB-SRyCzcbbhqP9ugC9jjDeBSXDD8rCs6nqFuVwYfeAMZxfFWY5whm_ZJN-6_394827a5IYdGu6Rn-0OmvSTq-5qqbvm753mjvfa4jOyu0antNcseU4eWPeCPG7mVf55SfTAwldRYVaG9kxV0HNw7qeAIOn49MeE0RNXAofVajGrLSxoR6dR5Qram-KoI4S2dHB2FuDMEGML2vcJeAtaOToCpfWKXAy_nvePg_WQhsAAElkGtowyAJkRM0JgbFhEuY254sVREesM-IBrkcVRyYtSGa4TgBQZYhqeR2mkQPz3yY6bOXtAqIpTW5qjXGFlhIq5MAiPBLawj1LDRId8bskk500vDgk-DFJXeupKpK701O2QL0jH23XYRdtfmN1M5fqgpfUqrjRlplQCyFFrKzRYB0C1sDkDL_nYcoEEqcNQinJ2tlpILDlPwTHhcYe8brji9lMtV3VItsUvW_-yfQe4wHf2XlP9zb2f_ECeTAZDeXoy_n5InuJxYN1kLN6SneXNyr4DALXU772o_AMIHRrK |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Deoxycholic+Acid+Triggers+NLRP3+Inflammasome+Activation+and+Aggravates+DSS-Induced+Colitis+in+Mice&rft.jtitle=Frontiers+in+immunology&rft.au=Zhao%2C+Shengnan&rft.au=Gong%2C+Zizhen&rft.au=Zhou%2C+Jiefei&rft.au=Tian%2C+Chunyan&rft.date=2016-11-28&rft.issn=1664-3224&rft.eissn=1664-3224&rft.volume=7&rft.spage=536&rft.epage=536&rft_id=info:doi/10.3389%2Ffimmu.2016.00536&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon |